Source link : https://www.newshealth.biz/health-news/de-intensified-therapy-misses-mark-in-hpv-positive-oropharyngeal-cancer/
Two strategies to de-escalate treatment for human papillomavirus (HPV)-positive oropharyngeal cancer failed to show noninferiority versus standard care, which “reset the bar” for future trials of de-escalation, a randomized trial showed. Standard treatment with a 70-Gy dose of radiation therapy (RT) plus cisplatin led to a 2-year progression-free survival (PFS) of 98.1%, as compared to […]
Author : News Health
Publish date : 2024-10-02 15:35:34
Copyright for syndicated content belongs to the linked Source.